Pfizer Covid-19 vaccine effectiveness upgraded in final analysis


Responsive image

Pfizer have announced that the final analysis of the trials of its Covid vaccine in 44,000 people have shown it to be effective in over 94% of those over 65. This follows on the positive results of the Moderna vaccine and the results from the Astra Zenica/Oxford vaccine are expected to be released soon.